Global Granisetron Market Overview:
Global Granisetron Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Granisetron Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Granisetron involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Granisetron Market:
The Granisetron Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Granisetron Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Granisetron Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Granisetron market has been segmented into:
Oral
Injection
Transdermal
By Application, Granisetron market has been segmented into:
Chemotherapy-Induced Nausea
Postoperative Nausea
Radiation-Induced Nausea
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Granisetron market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Granisetron market.
Top Key Players Covered in Granisetron market are:
Roche
Pfizer
Bristol-Myers Squibb
Fresenius Kabi
Sandoz
Apexigen
Eisai
Amgen
Merck
Hikma Pharmaceuticals
Genentech
Novartis
Sujan Pharmaceuticals
Mylan
Teva Pharmaceutical Industries
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Granisetron Market Type
4.1 Granisetron Market Snapshot and Growth Engine
4.2 Granisetron Market Overview
4.3 Oral
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Oral: Geographic Segmentation Analysis
4.4 Injection
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Injection: Geographic Segmentation Analysis
4.5 Transdermal
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Transdermal: Geographic Segmentation Analysis
Chapter 5: Granisetron Market Application
5.1 Granisetron Market Snapshot and Growth Engine
5.2 Granisetron Market Overview
5.3 Chemotherapy-Induced Nausea
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Chemotherapy-Induced Nausea: Geographic Segmentation Analysis
5.4 Postoperative Nausea
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Postoperative Nausea: Geographic Segmentation Analysis
5.5 Radiation-Induced Nausea
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Radiation-Induced Nausea: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Granisetron Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ROCHE
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 PFIZER
6.4 BRISTOL-MYERS SQUIBB
6.5 FRESENIUS KABI
6.6 SANDOZ
6.7 APEXIGEN
6.8 EISAI
6.9 AMGEN
6.10 MERCK
6.11 HIKMA PHARMACEUTICALS
6.12 GENENTECH
6.13 NOVARTIS
6.14 SUJAN PHARMACEUTICALS
6.15 MYLAN
6.16 TEVA PHARMACEUTICAL INDUSTRIES
Chapter 7: Global Granisetron Market By Region
7.1 Overview
7.2. North America Granisetron Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Oral
7.2.2.2 Injection
7.2.2.3 Transdermal
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Chemotherapy-Induced Nausea
7.2.3.2 Postoperative Nausea
7.2.3.3 Radiation-Induced Nausea
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Granisetron Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Oral
7.3.2.2 Injection
7.3.2.3 Transdermal
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Chemotherapy-Induced Nausea
7.3.3.2 Postoperative Nausea
7.3.3.3 Radiation-Induced Nausea
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Granisetron Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Oral
7.4.2.2 Injection
7.4.2.3 Transdermal
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Chemotherapy-Induced Nausea
7.4.3.2 Postoperative Nausea
7.4.3.3 Radiation-Induced Nausea
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Granisetron Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Oral
7.5.2.2 Injection
7.5.2.3 Transdermal
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Chemotherapy-Induced Nausea
7.5.3.2 Postoperative Nausea
7.5.3.3 Radiation-Induced Nausea
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Granisetron Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Oral
7.6.2.2 Injection
7.6.2.3 Transdermal
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Chemotherapy-Induced Nausea
7.6.3.2 Postoperative Nausea
7.6.3.3 Radiation-Induced Nausea
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Granisetron Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Oral
7.7.2.2 Injection
7.7.2.3 Transdermal
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Chemotherapy-Induced Nausea
7.7.3.2 Postoperative Nausea
7.7.3.3 Radiation-Induced Nausea
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Granisetron Scope:
|
Report Data
|
Granisetron Market
|
|
Granisetron Market Size in 2025
|
USD XX million
|
|
Granisetron CAGR 2025 - 2032
|
XX%
|
|
Granisetron Base Year
|
2024
|
|
Granisetron Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Roche, Pfizer, Bristol-Myers Squibb, Fresenius Kabi, Sandoz, Apexigen, Eisai, Amgen, Merck, Hikma Pharmaceuticals, Genentech, Novartis, Sujan Pharmaceuticals, Mylan, Teva Pharmaceutical Industries.
|
|
Key Segments
|
By Type
Oral
Injection
Transdermal
By Applications
Chemotherapy-Induced Nausea
Postoperative Nausea
Radiation-Induced Nausea
|
